We and others previously established that VP, as measured by copeptin, is an independent risk factor for diabetes, the metabolic syndrome, chronic kidney disease, cardiovascular disease and premature death in the population [11, 15–17, 29, 30]. This evidence concerns the gene AVP and chronic kidney disease.